Interest In Hybrid Trials Increases
Source: Life Science Leader
By Industry Standard Research
While outsourcing respondents currently hold mixed opinions on conducting hybrid trials (some traditional and some decentralized components), over two-thirds either currently use or plan to use them in the next two years. Respondents also anticipate that hybrid trials will make up a greater proportion of their studies two years from now. This is starkly illustrated in the bar graph below, where 14% of respondents currently — and 31% two years from now — use hybrid strategies for at least 40% of their trials.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more